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Role of macula densa adenosine triphosphate (ATP) in tubu-
loglomerular feedback.
Background. Recent studies have shown that adenosine
triphosphate (ATP) is liberated from macula densa cells in
response to increased tubular NaCl in vitro. We tested the
hypothesis that increased NaCl in the macula densa stimu-
lates the release of ATP, resulting in extracellular formation
of adenosine which is involved in signal transmission of the
tubuloglomerular feedback response.
Methods. Rabbit afferent arterioles and attached macula
densas were simultaneously microperfused in vitro. Tubu-
loglomerular feedback was induced by increasing macula densa
Na/Cl from 11/10 to 81/80 mmol/L and was measured before and
after treatment.
Results. We first tested whether hydrolysis of ATP is required
for tubuloglomerular feedback. When we enhanced conver-
sion of ATP to adenosine by adding hexokinase or apyrase
to the bath and arteriole lumen, the tubuloglomerular feed-
back response was augmented. During the control period, tubu-
loglomerular feedback decreased arteriole diameter by 2.2 ±
0.2 lm. In the presence of hexokinase, tubuloglomerular feed-
back decreased diameter by 3.4 ± 0.3 lm (N = 8) (P < 0.05, with
vs. without hexokinase). In the apyrase group, tubuloglomeru-
lar feedback decreased diameter by 2.7 ± 0.4 lm during the
control period. When apyrase was added, tubuloglomerular
feedback decreased diameter by 4.7 ± 0.4 lm (N = 8) (P <
0.05, with vs. without apyrase). When hydrolysis of adenosine
monophosphate (AMP) to adenosine was blocked by supple-
menting the bath with 100 lmol/L a,b-methylene adenosine
5′-diphosphate (MADP), an inhibitor of 5′-nucleotidase, tubu-
loglomerular feedback response was blocked and diameter re-
mained unchanged. We next studied whether ATP released
from the macula densa binds to P2 receptors and activates the
tubuloglomerular feedback response. The P2 purinergic recep-
tor inhibitor suramin was added to both arteriole lumen and
bath. During the control period, tubuloglomerular feedback
decreased diameter by 3.7 ± 0.5 lm. Suramin (100 lmol/L) did
not significantly inhibit tubuloglomerular feedback, since in the
presence of suramin diameter decreased by 3.8±0.3 lm (N =7).
Finally, we added the adenosine A1 receptor inhibitor FK838
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to both bath and lumen and found that it completely blocked
high NaCl-induced tubuloglomerular feedback.
Conclusion. We concluded that ATP released from the mac-
ula densa is broken down to form AMP in the extracellu-
lar space. AMP in turn is degraded by ecto-5′-nucleotidases
to adenosine, which mediates signal transmission of the tubu-
loglomerular feedback response.
Recent studies have shown that adenosine triphos-
phate (ATP) is liberated from macula densa cells in re-
sponse to increased tubular NaCl delivery in vitro [1].
Additionally, ATP levels in the interstitium of the renal
cortex are increased by maneuvers that cause a tubu-
loglomerular feedback response [2]. Extracellular ATP
may exert its biologic effects directly via its P2 puriner-
gic receptor, or indirectly via hydrolysis by ectonu-
cleotidases, forming adenosine which binds to adenosine
receptors. Regardless of the ultimate source, adenosine
has been implicated as integral to the tubuloglomerular
feedback response. Peritubular infusions of theophylline,
which competes with adenosine for A1 receptors, at-
tenuated the tubuloglomerular feedback–induced fall in
single-nephron glomerular filtration rate (SNGFR) and
stop-flow pressure (SFP) [3, 4]. In corollary experiments,
dipyridamole, an inhibitor of adenosine uptake that in-
creases interstitial adenosine concentrations, potentiated
tubuloglomerular feedback [3]. We have shown that A1
antagonists block tubuloglomerular feedback [5]. Other
maneuvers that reduced extracellular adenosine concen-
trations, such as infusions of adenosine deaminase, also
attenuated tubuloglomerular feedback activity, whereas
infusion of an adenosine deaminase inhibitor enhanced
tubuloglomerular feedback [6]. However, P2 purinergic
receptors have been found in the renal vasculature. This
raised another possibility, that ATP is released from mac-
ula densa cells and evokes tubuloglomerular feedback–
dependent preglomerular vasoconstriction directly. It is
not clear whether the ATP released from the macula
densa is broken down to adenosine and participates in
the tubuloglomerular feedback response, or whether it
binds to ATP receptors and stimulates tubuloglomerular
feedback.
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The present studies were performed to test the hypoth-
esis that ATP released from the macula densa in response
to increased NaCl is primarily broken down to form extra-
cellular adenosine which contributes to signal transmis-
sion of the tubuloglomerular feedback response. Three
approaches were utilized to evaluate this hypothesis: (1)
enhancement of hydrolysis of ATP to adenosine diphos-
phate (ADP) and adenosine, (2) prevention of adeno-
sine formation by 5′-nucleotidase, and (3) blockade of
the ATP class of purinergic receptor P2 or adenosine A1
receptors.
METHODS
Afferent arterioles with macula densa attached were
isolated and microperfused as described previously [7–
9]. Briefly, young male New Zealand white rabbits (1.5 to
2.0 kg) were fed standard rabbit chow (Ralston Purina,
St. Louis, MO, USA) and given tap water ad libitum. They
were anesthetized with sodium pentobarbital (40 mg/kg,
intravenously) and given an injection of heparin (500 U,
intravenously). The kidneys were sliced along the cor-
ticomedullary axis, and slices were placed in ice-cold
minimum essential medium (MEM) (Gibco, Grand Is-
land, NY, USA) containing 5% bovine serum albumin
(BSA; Intergen, Burlington, MA, USA). A single super-
ficial afferent arteriole and its intact glomerulus from
each rabbit were microdissected together with adher-
ent tubular segments consisting of portions of the thick
ascending limb, macula densa, and early distal tubule.
Samples were transferred to a temperature-regulated
chamber mounted on an inverted microscope (Olympus
IMT-2, Tokyo, Japan) with Hoffmann modulation. Both
the afferent arteriole and the end of either the distal
tubule or thick ascending limb were cannulated with an
array of glass pipettes as described previously [8]. Intralu-
minal pressure of the afferent arteriole was measured by
Landis’ technique, using a fine pipette introduced into the
lumen through the perfusion pipette. The afferent arteri-
ole was perfused with MEM supplemented with 5% BSA
and (in mmol/L) 5 NaHCO3, 10 NaCl, 10 HEPES, and 10
NaOH. Intraluminal pressure was maintained at 60 mm
Hg throughout the experiment. The macula densa was
perfused with physiologic saline consisting of (in mmol/L)
10 HEPES, 1.0 CaCO3, 0.5 K2HPO4, 4.0 KHCO3,
1.2 MgSO4, 5.5 glucose, 0.5 Na acetate, 0.5 Na lactate, and
either 80 (high NaCl) or 10 NaCl (low NaCl). MEM was
gassed with air and physiologic saline was oxygenated
with 100% O2. The pH of each solution was 7.4. The
bath was similar to the arteriolar perfusate except that it
contained 0.15% BSA, and was exchanged continuously
at a rate of 1 mL/min. Microdissection and cannulation
were completed within 90 minutes at 8◦C, after which the
bath was gradually warmed to 37◦C for the rest of the ex-
periment. Once the temperature was stable, a 30-minute
equilibration period was allowed before taking any mea-
surements. Images were displayed at magnifications up
to 1980× and recorded with a video system. Afferent ar-
teriole diameter was measured with a MetaMorph image
analysis system (Universal Imaging, West Chester, PA,
USA).
Experimental protocols
Time control. First we conducted time control ex-
periments showing that during two consecutive tubu-
loglomerular feedback responses the afferent arteriole
reacted in a similar fashion. After a 30-minute equili-
bration period, NaCl concentrations of the macula densa
perfusate were increased from low to high. Five minutes
later, the macula densa perfusate was switched back to
low NaCl and a second tubuloglomerular feedback re-
sponse was induced by increasing the macula densa per-
fusate to high NaCl.
Effect of enhanced hydrolysis of ATP on afferent ar-
teriole constriction induced by high NaCl at the macula
densa. To determine whether an increase in hydrol-
ysis of ATP released from the macula densa potenti-
ates the tubuloglomerular feedback response, we added
ATPases to the bath to facilitate hydrolysis of ATP and
thereby increase adenosine formation. The macula densa
was first perfused with low-NaCl solution for 5 minutes,
and then the perfusate was changed to high NaCl. Five
minutes later, the macula densa perfusate was switched
back to low NaCl and hexokinase (20 U/mL) or apyrase
(5 U/mL), which hydrolyzes ATP to adenosine, was added
to the bath and arteriole lumen. Following a 20-minute
equilibration period, the macula densa perfusate was
changed to high NaCl. These concentrations of ATPases
have been reported to effectively increase ATP hydroly-
sis [10, 11].
Effect of 5′-nucleotidase blockade on afferent arteriole
constriction induced by high NaCl at the macula densa.
To determine whether tubuloglomerular feedback re-
quires adenosine, we examined the maximum response
of the afferent arteriole to increased NaCl at the mac-
ula densa before and after inhibiting the exoenzyme 5′-
nucleotidase, which converts adenosine monophosphate
(AMP) to adenosine. The experiments were performed
as described above. The macula densa was first per-
fused with low-NaCl solution for 5 minutes, and then
the perfusate was changed to high NaCl. Five minutes
later, the macula densa perfusate was switched back
to low NaCl and a,b-methylene adenosine diphosphate
(MADP) (10−4 mol/L), an inhibitor of 5′-nucleotidase,
was added to the bath. Following a 20-minute equilibra-
tion period, the macula densa perfusate was changed to
high NaCl.
Effect of adenosine A1 receptor blockade on afferent
arteriole constriction induced by high NaCl at the mac-
ula densa. To determine whether the tubuloglomerular
feedback response relies on stimulation of adenosine A1
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receptors, we measured tubuloglomerular feedback be-
fore and after blocking these receptors. The experiments
were performed as described above. The macula densa
was first perfused with low-NaCl solution for 5 minutes,
and then the perfusate was changed to high NaCl. Five
minutes later, the macula densa perfusate was switched
back to low NaCl and an adenosine A1 receptor blocker,
FK838 (10−6 mol/L), was added to the arteriole lumen
and bath. We previously reported that FK838 at this con-
centration completely blocked the vasoconstrictor action
of exogenous adenosine (10−6 mol/L) on the afferent ar-
teriole [5].
Effect of P2 receptor blockade on afferent arteriole
constriction induced by high NaCl at the macula densa.
To determine whether ATP released from the mac-
ula densa binds to another cell type and activates the
tubuloglomerular feedback response, we examined tubu-
loglomerular feedback response before and after block-
ing the P2 receptors. The experiments were performed
as described above, except that a P2 receptor blocker,
suramin (10−4 mol/L), was added to the arteriole lumen
and bath. This concentration of suramin has been shown
to completely block ATP-induced increases in intracellu-
lar calcium in an isolated perfused macula densa prepa-
ration [12].
Statistics
Values are expressed as mean ± SEM. A paired t test
was used to examine whether the diameter at a given
concentration differed from control. P < 0.05 was con-
sidered significant using Bonferroni’s correction for mul-
tiple comparisons.
RESULTS
Time control
In time controls, afferent arteriole diameter decreased
from 17.7 ± 0.7 lm to 14.2 ± 1.4 lm when the solution
perfusing the macula densa was first changed from low
to high NaCl. When we repeated the process, diameter
decreased from 17.7 ± 1.0 lm to 14.9 ± 1.0 lm. The two
consecutive tubuloglomerular feedback responses were
not significantly different (N = 5).
Effect of enhanced hydrolysis of ATP on afferent
arteriole constriction induced by high NaCl at the
macula densa
In the first series of experiments, we added an ATPase
to the bath to facilitate hydrolysis of ATP after it is re-
leased from the macula densa, thereby increasing adeno-
sine formation. We first enhanced conversion of ATP to
ADP and adenosine by adding hexokinase (20 U/mL) to
the bath. When the macula densa perfusate was changed
from low to high NaCl, tubuloglomerular feedback de-
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Fig. 1. Effect on tubuloglomerular feedback (TGF) caused by adding
hexokinase to the bath to enhance conversion of adenosine triphosphate
(ATP) to adenosine diphosphate (ADP) and adenosine. (A) Afferent
arteriole (Af-Art) constriction induced by increased NaCl at the macula
densa. (B) Tubuloglomerular feedback response. Increased conversion
of ATP to adenosine enhanced tubuloglomerular feedback, suggesting
that ATP released from the macula densa was hydrolyzed to adenosine
which participated in the tubuloglomerular feedback response. ∗P <
0.05, with vs. without hexokinase (N = 8).
creased afferent arteriole diameter by 2.2 ± 0.2 lm (from
18.5 ± 1.0 lm to 16.3 ± 0.9 lm) (N = 8). When the solution
was changed to low NaCl, diameter returned to 18.8 ± 1.0
lm. Adding hexokinase (20 U/mL) to the bath did not
alter afferent arteriole diameter when the macula densa
was perfused with low NaCl (18.8 ± 1.0 lm vs. 17.8 ±
1.0 lm), but augmented constriction when the macula
densa perfusate was changed to high NaCl. Diameter de-
creased by 3.4 ± 0.3 lm (from 17.8 ± 1.0 lm to 14.1 ±
1.0 lm) (P < 0.05, with vs. without hexokinase) (Fig. 1).
To confirm this, we suffused the bath and afferent arteri-
ole lumen with apyrase (5 U/mL), which also facilitates
hydrolysis of ATP to ADP and adenosine. When NaCl
was increased from low to high, TGF decreased arteriole
diameter by 2.7 ± 0.4 lm (from 20.0 ± 0.7 lm to 17.3 ±
0.5 lm). Adding apyrase to the bath and lumen sig-
nificantly enhanced the tubuloglomerular feedback re-
sponse. Diameter decreased by 4.7 ± 0.4 lm (from 19.4 ±
0.7 lm to 14.7 ± 0.5 lm) (N = 8) (P < 0.05, with vs. with-
out apyrase) (Fig. 2).
Effect of 5′-nucleotidase blockade on afferent arteriole
constriction induced by high NaCl at the macula densa
Next, we investigated whether adenosine formation is
essential for the tubuloglomerular feedback response.
The 5′-nucleotidase blocker MADP was added to the
bath. As shown in Figure 3, when the macula densa
perfusate was changed from low to high NaCl, tubu-
loglomerular feedback decreased afferent arteriole di-
ameter by 3.4 ± 0.5 lm (from 19.7 ± 1.1 lm to 16.4 ±
1.5 lm). When the luminal solution was switched back to
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Fig. 2. Effect on tubuloglomerular feedback (TGF) caused by adding
apyrase to the bath and lumen to enhance conversion of adenosine
triphosphate (ATP) to adenosine diphosphate (ADP) and adenosine.
(A) Afferent arteriole (Af-Art) constriction induced by increased NaCl
at the macula densa. (B) Tubuloglomerular feedback response. In-
creased conversion of ATP to adenosine significantly augmented tubu-
loglomerular feedback. ∗P < 0.05, with vs. without apyrase (N = 8).
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Fig. 3. Effect on tubuloglomerular feedback (TGF) caused by adding
a,b-methylene adenosine 5′-diphosphate (MADP) to the bath to block
5′-nucleotidase. (A) Afferent arteriole (Af-Art) constriction induced by
increased NaCl at the macula densa. (B) Tubuloglomerular feedback
response. In the presence of MADP, tubuloglomerular feedback was
eliminated, suggesting that formation of adenosine is essential for the
tubuloglomerular feedback response. ∗P < 0.05, with vs. without MADP
(N = 8).
low NaCl, diameter returned to baseline. When MADP
at 10−4 mol/L was added to the low-NaCl macula densa
perfusate, it did not alter afferent arteriole diameter
(19.9 ± 1.0 lm vs. 19.7 ± 1.0 lm). When the mac-
ula densa perfusate was changed to high NaCl in the
presence of MADP, which blocks adenosine formation,
the tubuloglomerular feedback response was completely
suppressed and afferent arteriole diameter remained un-
changed (from 19.7 ± 1.04 lm to 19.4 ± 1.1 lm) (N = 8)
(P < 0.05, with vs. without MADP).
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Fig. 4. Effect of FK838, an adenosine A1 receptor antagonist, on affer-
ent arteriole constriction induced by high NaCl at the macula densa. (A)
Afferent arteriole (Af-Art) constriction induced by increased NaCl at
the macula densa. (B) Tubuloglomerular feedback response. Treatment
with FK838 had no effect on basal diameter but completely blocked the
constriction induced by high NaCl at the macula densa. ∗P < 0.05, with
vs. without FK838 (N = 8).
Effect of adenosine A1 receptor blockade on afferent
arteriole constriction induced by high NaCl at the
macula densa
We next investigated whether tubuloglomerular feed-
back relies on activation of the adenosine A1 receptor.
For this, we examined the maximum response of the
afferent arteriole to increased NaCl concentrations at
the macula densa before and after blocking the adeno-
sine A1 receptor. During the control period, when NaCl
was increased from low to high, tubuloglomerular feed-
back decreased arteriole diameter by 3.2 ± 0.5 lm (from
18.3 ± 0.9 lm to 15.1 ± 1.3 lm). Adding FK838 to the
bath and afferent arteriole lumen completely abolished
the tubuloglomerular feedback response. When macula
densa NaCl was changed from low to high, afferent ar-
teriole diameter remained unchanged (19.4 ± 1.4 lm vs.
19.0 ± 0.9 lm) (N = 8) (P < 0.05, with vs. without FK838)
(Fig. 4). To test the possibility that the inhibitory effect of
FK838 on tubuloglomerular feedback involves blockade
of both the adenosine A1 receptor and the P2 puriner-
gic receptor, we perfused the afferent arteriole alone and
studied its response to exogenous ATP in the presence
of FK838. We first generated a dose-response curve with
ATP as a control, then added FK838 (10−6 mol/L) to the
bath and arteriole lumen and generated a second ATP
dose-response curve. Figure 5 illustrates the afferent ar-
teriole response to ATP in the absence or presence of
FK838. ATP constricted the afferent arteriole in a dose-
dependent manner. One and 10 lmol/L ATP reduced ar-
teriole diameter from 20.1 ± 0.7 lm to 17.4 ± 1.0 lm
and 16.2 ± 0.9 lm, respectively. When arterioles were
treated with FK838, ATP-induced constriction remained
unchanged.
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Fig. 5. Effect of FK838 on afferent arteriole response to exogenous
adenosine triphosphate (ATP). We first generated a dose-response
curve with ATP as a control (). Then we added 10−6 mol/L FK838
to the bath and afferent arteriole lumen and generated a second ATP
dose-response curve (). FK838 did not alter the afferent arteriole (Af-
Art) response to ATP, suggesting that FK838 at this concentration does
not block the P2 receptor (N = 6).
Effect of P2 receptor blockade on afferent arteriole
constriction induced by high NaCl at the macula densa
We next examined the effect of suramin, a P2 puriner-
gic receptor blocker, on the tubuloglomerular feedback
response. During the control period, when NaCl was in-
creased from low to high, tubuloglomerular feedback de-
creased afferent arteriole diameter by 3.8 ± 0.5 lm (from
19.5 ± 1.2 lm to 15.8 ± 1.4 lm). Adding suramin to the
bath and arteriole lumen did not alter the tubuloglomeru-
lar feedback response. When macula densa NaCl was
changed from low to high, tubuloglomerular feedback
decreased arteriole diameter by 3.8 ± 0.3 lm, the same
as control (from 18.9 ± 1.1 lm to 15.0 ± 1.3 lm) (N = 7)
(Fig. 6).
DISCUSSION
Our findings suggest that ATP released from the mac-
ula densa in response to increased NaCl is rapidly metab-
olized to ADP, AMP, and ultimately adenosine by the cell
surface ectonucleotidases involved in the tubuloglomeru-
lar feedback response. This is supported by the fact that
when we prevented adenosine formation with MADP,
which blocks 5′-nucleotidase, the tubuloglomerular feed-
back response was abolished; and conversely, when we
enhanced ATP hydrolysis with hexokinase or apyrase
and thereby increased adenosine formation, the tubu-
loglomerular feedback response was augmented. More-
over, blocking the adenosine A1 receptor with FK838
inhibited tubuloglomerular feedback, whereas suramin,
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Fig. 6. Effect of suramin, a P2 receptor antagonist, on afferent arteri-
ole constriction induced by high NaCl at the macula densa. (A) Afferent
arteriole (Af-Art) constriction induced by increased NaCl at the mac-
ula densa. (B) Tubuloglomerular feedback response. Treatment with
suramin did not alter the tubuloglomerular feedback response, sug-
gesting that activation of P2 receptors may not play an important role
in tubuloglomerular feedback (N = 7).
which blocks the P2 receptor, did not influence the tubu-
loglomerular feedback response.
Macula densa cells are thought to be richly endowed
with small mitochondria distributed along the basal and
lateral aspects [13, 14] and exhibit relatively low Na+-
K+-ATPase activity [15], supporting the concept that
they possess substantial ATP-generating capacity. Re-
cent in vitro studies have shown that macula densa
cells release ATP in response to increased tubular NaCl
delivery [1], and ATP is increased in the cortical in-
terstitium by maneuvers that cause tubuloglomerular
feedback [2]. Extracellular hydrolysis of nucleotides is
catalyzed by several classes of membrane-bound enzymes
called ectonucleotidases. Biochemically, these enzymes
are characterized by their ability to hydrolyze purine and
the pyrimidines nucleoside di- and triphosphate. These
enzymes are widely expressed in many tissues, including
the kidney, and hydrolysis of ATP can be a rapid pro-
cess with half-degradation times of well under 1 minute.
The final step in the conversion of interstitial adenine nu-
cleotides to adenosine is catalyzed by the action of ecto-
5′-nucleotidase. This enzyme is widely distributed in the
kidney and expressed in all nephron segments, including
macula densa cells. It is also expressed by fibroblasts and
mesangial cells [16–18]. To clarify whether the ATP re-
leased from the macula densa is broken down to form the
adenosine involved in the tubuloglomerular feedback re-
sponse, we used a 5′-nucleotidase blocker or ATPases
to either inhibit 5′-nucleotidase or increase hydrolysis
of ATP and thereby alter the formation of adenosine.
Our results demonstrated that blocking 5′-nucleotidase
with MADP, which prevents formation of adenosine,
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abolished the tubuloglomerular feedback response,
whereas enhancing the conversion of ATP to ADP and
AMP, which increases the formation of adenosine, aug-
mented the tubuloglomerular feedback response. This
suggests that ATP released from the macula densa must
be hydrolyzed to adenosine in order to effect a tubu-
loglomerular feedback response. Taking together the
demonstration of regulated release of ATP by mac-
ula densa cells and the evidence for adenosine depen-
dence of tubuloglomerular feedback, we may assume
that ATP is metabolized to adenosine via ADP and
AMP within the confines of the juxtaglomerular inter-
stitium. Consistent with our studies, Thomson et al [19]
demonstrated that tubuloglomerular feedback efficiency
and range were both significantly reduced by blocking
5′-nucleotidase.
Because adenosine is a major metabolic end prod-
uct and is known to elicit vasoactive effects, it has been
viewed as one possible paracrine factor that transmits
signals from the macula densa to mediate the tubu-
loglomerular feedback response. In situ hybridization has
shown a high density of A1 receptor mRNA in the termi-
nal segment of the afferent arteriole [20, 21]. Several stud-
ies using a variety of techniques have examined the direct
effect of adenosine on the resistance of renal glomerular
arterioles. There is general agreement that the adenosine
A1 receptor mediates vasoconstriction in the afferent ar-
teriole [21, 22]. On the other hand, abundant evidence
indicates that extracellular ATP exerts its biologic effects
by activating members of the P2 class of purinoceptors.
Autoradiography showing binding of the P2X ligand in
the interlobular arteries and afferent arteriole supports
the preglomerular localization of P2X receptors [23]. In
isolated perfused rabbit afferent arterioles, ATP added to
the bath caused vasoconstriction that was probably medi-
ated by P2X receptors, because b ,c-methylene ATP had
the same effect [21]. To test whether the tubuloglomeru-
lar feedback response relies on adenosine A1 or puriner-
gic P2 receptors, we tested both an A1 receptor antag-
onist (FK838) and a P2 receptor antagonist (suramin).
Blocking the adenosine A1 receptor with FK838 abol-
ished the tubuloglomerular feedback response whereas
blocking the purinergic P2 receptor with suramin did not,
suggesting that activation of the A1 receptor by adeno-
sine is a necessary component of the tubuloglomerular
feedback pathway, but activation of the P2 receptor may
not play a very important role in tubuloglomerular feed-
back. Microperfusion studies in A1 receptor knockout
mice clearly showed complete absence of tubuloglomeru-
lar feedback responses, with no detectable drop in stop-
flow pressure after increased distal fluid delivery [24, 25],
in agreement with the original suggestion made by Oss-
wald et al [3] and our present studies where adenosine was
a mediator rather than a modulator of the tubuloglomeru-
lar feedback mechanism.
In our in vitro studies, which directly addressed the
tubuloglomerular feedback response, we found that ad-
dition of a P2 receptor antagonist to the bath and affer-
ent arteriole lumen did not alter the tubuloglomerular
feedback response. In contrast to our results, others have
reported that P2 receptors mediate tubuloglomerular
feedback; however, they examined afferent arterioles
from rats and P2X1 knockout mice using the jux-
tamedullary nephron technique [26]. While the reason
for this discrepancy is not clear, it may be related to the
different species used and/or systemic neurohormonal
influences. Another possibility is the different location
of the afferent arteriole(s) studied. Regulation of the
tubuloglomerular feedback mechanism may differ in re-
nal cortex vs. juxtamedullary nephrons due to different
responsiveness of superficial cortex vs. juxtamedullary
afferent arterioles to neurohormonal factors. Vasocon-
striction caused by adenosine is reportedly higher in
superficial cortex compared to juxtamedullary afferent
arterioles [21, 22]. Furthermore, afferent arterioles ex-
hibit a higher sensitivity to luminal angiotensin II in renal
cortex but not juxtamedullary nephrons [27].
CONCLUSION
ATP released from the macula densa is broken down
to form AMP in the extracellular space. AMP in turn is
degraded by ecto-5′-nucleotidases to adenosine, which
mediates signal transmission of the tubuloglomerular
feedback response.
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